test altFunding OpportunitiesAward ManagementComliance Review and OversightEducation and TrainingTechnology Transfer
Office of Research and Technology Management
Promoting Research, Advancing Scholarship, Fostering Innovation
Identify Funding Oportunities Proposal Development Award Management
Compliance Review and Oversight Education and Training Technology Transfer


Welcome from the Vice President for Research

CWRU researchers are among the most distinguished in the world. We have 16 Nobel Laureates among current and former faculty and alumni, 4 members of the National Academies of Sciences, 7 members of the National Academy of Engineering, and 8 members of the Institute of Medicine. We also partner with artistic and cultural institutions on a broad range of projects that make important scholarly contributions in the humanities and social sciences.

Extraordinary research requires an outstanding infrastructure. Our Office of Research & Technology Management provides support to seek out grant funding, to facilitate industrial sponsorship, and to transfer university technologies to the marketplace. This is a place for people driven to make a difference, and our office exists to help them succeed.

Contact us. We want you to see what our campus can offer.

Dr. Suzanne Rivera


Research Matters

Research Matters

Use the following link in order to view previous editions of Research Matters and Research News and Updates Research Matters Archive .




Latest News

Research Newsletter
May 14, 2015  

Reminder: New NIH biosketch format effective May 25th, 2015

The new NIH Biosketch format will take effect for applications submitted on or after May 25, 2015. Key changes include:

  • Extending the biosketch page limit to 5 pages
  • Allowing PIs and researchers to include up to four references in their personal statement
  • Allowing researchers to describe up to five of their most important contributions to science
  • Allowing researchers to include a link that provides access to a full list of your published work

Kathy Blazar, interim director at our Cleveland Health Sciences Library, has prepared a power point presentation that can help you navigate the new format: http://www.case.edu/chsl/library/NIHBiosketch.pptx.

Additional points to consider:
  • Investigators need to update their personal profile on eRA Commons
  • Public access compliance need to be up to date
  • All non-CWRU, most especially international, collaborators must also be compliant if they are named as key personnel.
If you have questions about the process, please contact Kathy Blazar at kcb2@case.edu.

 
Department of Health and Human Services – Administration for Children & Families

This Funding Opportunity Announcement (FOA) solicits applications for the Competitive Abstinence Education (CAE) program. The purpose of the CAE program is to provide funding for additional tools to address the rates of teen pregnancy among adolescent youth who are at greatest risk of sexually transmitted infections and most likely to bear children out of wedlock. Program plans will focus on the social, psychological, and health gains to be realized by delaying initiation of sexual activity and engaging in healthy relationships. Grantees under this program will be expected to develop a targeted and medically accurate approach to reducing teen pregnancies through abstinence education.

Application Deadline: June 24, 2015

For more information visit the Grants.Gov webpage.

 
Ferring Pharmaceuticals

Ferring Pharmaceuticals is pleased to announce that the Ferring Innovation Grants Portal is now open and accepting applications. The goal of the Ferring Innovation Grants program is to fund projects designed to identify novel drug targets that are:

  • For indications within their core therapeutic areas (Reproductive Health, Urology, Gastroenterology)

  • Addressable with peptides and/or proteins

  • Exploratory, discovery and/or preclinical in nature


The program will provide a limited number of grants in the amount of $50,000. The grants DO NOT carry indirect costs and are not renewable. Funding will not be provided for clinical studies, studies which require collection of patient biopsies or studies to develop small molecules. In all cases the intellectual property rights remain with the applicant.

Application Deadline: July 1st, 2015

For more information visit the Ferring Pharmaceuticals webpage.

 
Limited Submission Reminder: Pew Scholars Program in the Biomedical Sciences

Key Deadlines: June 1, 2015 (CWRU internal letter of intent), July 15, 2015 (Institution formally nominates candidate), November 16, 2015 (Sponsor's submission deadline).

The Pew Scholars Program in the Biomedical Sciencesprovides funding to young investigators of outstanding promise in science relevant to the advancement of human health. The program makes grants to selected academic institutions to support the independent research of outstanding individuals who are in their first few years of their appointment at the assistant professor level.

Number of Applications Allowed: One application per organization.

Amount of Funding: $240,000 ($60,000 a year for four years)

For more information on this limited submission opportunity, visit the Office of Research Administration website.

 
Limited Submission Reminder: W.M. Keck Foundation Research Program

Key Deadlines: June 15, 2015 (CWRU internal LOI), November 1, 2015 (Sponsor Deadline).

The W.M. Keck Foundation Research Program seeks to benefit humanity by funding fundamental, high-risk research in two specific areas: 1) medical research and 2) science and engineering. Both Senior and Early Career investigators are encouraged to apply. CWRU may submit two proposals per funding cycle: one (1) in Medical Research and one (1) in Science and Engineering Research.

Applicants are encouraged to consult with their Associate Deans for Research prior to internal submission to assure they meet eligibility criteria and their projects meet stated program objectives.

Grants of up to $1 million over 3 years are awarded for projects in science and engineering research and medical research that:

  • Focus on basic, early stage, emerging areas of research, not on clinical or translational research, treatment trials or research for the sole purpose of drug development.
  • Have the potential to develop breakthrough technologies, instrumentation or methodologies.
  • Have few, if any, peer groups pursuing comparable or related work.
  • Have high level of risk due to unconventional approaches, or by challenging the prevailing paradigm.
  • Have the potential for transformative impact, such as the founding of a new field of research, the enabling of observations not previously possible, or the altered perception of a previously intractable problem.
  • Fall outside the mission of public funding agencies. Provide specifics. If you've been declined federal funding, provide the documentation stating why, if available.
  • Demonstrate that the W. M. Keck Foundation's support is essential to the project's success.


For more information on this limited submission opportunity, visit the Office of Research Administration website.

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.